Repare Therapeutics Inc is a company in the field of precision cancer research, thanks to its proprietary synthetic lethality approach to the discovery and development of new therapeutics. Synthetic Lethality (SL), is a clinically validated approach to drug development.
P/E
Net profit
P/B
Book value
P/FCF
FCF
Yield
Growth potential
Repare Therapeutics news
12.11.2020
The loss of Repare Therapeutics under GAAP for 9 months of 2020 amounted to $38.154 million, having doubled compared to $18.885 million in the previous year.
Source: 
ir.reparerx.com
ir.reparerx.com
14.08.2020
The loss of Repare Therapeutics under GAAP for 6 months of 2020 amounted to $24.403 million, an increase of 2.1 times compared to $11.197 million in the previous year.
Source: ir.reparerx.com
ir.reparerx.com
General information
| Company name | Repare Therapeutics |
|---|---|
| Sector | Health Care / Pharmaceuticals, Biotechnology & Life Sciences / Pharmaceuticals / Pharmaceuticals |
| Business address | 7210 FREDERICK-BANTING, SUITE 100 ST-LAURENT A8 H4S 2A1 (857) 412-7018 |
| Mailing address | 7210 FREDERICK-BANTING, SUITE 100 ST-LAURENT A8 H4S 2A1 |
| Website | www.reparerx.com |
| Information disclosure | www.sec.gov |
English (US) 